Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Hydroxychloroquine can help treat certain types of hair loss.

New treatments for hair loss are being developed using molecular biology.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Mesotherapy is a promising alternative to minoxidil for hair loss with mild side effects.

A new classification for depth control in hair restoration surgery was proposed, dividing it into three grades based on the depth required for successful graft extraction.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Esthetic surgery complications can include infections, nerve injury, and more; proper evaluation and technique help prevent them.

Baricitinib is effective and safe for treating severe alopecia areata.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Laser treatment can effectively reduce unwanted hair growth, particularly for people with fair skin and dark hair.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Caffeine may benefit skin and hair health but more research is needed to confirm its effectiveness in dermatology.

Early treatment can reverse hair loss from dermal fillers.

Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Genetic variants can affect valproic acid's effectiveness, side effects, and levels in epilepsy treatment.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

Certain genes and pathways are linked to the production of finer and denser wool in Hetian sheep.

CD2 might be a new treatment target for patchy alopecia areata.